Recombinant Human GCKR Protein: Handling & Usage Protocol
Recombinant Human GCKR Protein: Handling & Usage Protocol
Recombinant Human GCKR Protein is a critical research tool for studying glucokinase regulation, metabolic signaling, and type 2 diabetes-associated pathways, requiring careful handling to preserve its biological activity and structural integrity.
- Product Name
- Recombinant Human GCKR Protein
- SKU
- rp367929
- Protein Function
- Regulates glucokinase (GCK) activity; inhibits GCK in low glucose and activates it in response to fructose-1-phosphate
- Recommended Storage
- -80°C for long-term storage; avoid repeated freeze-thaw cycles
- Reconstitution
- Reconstitute in sterile water or appropriate buffer as specified in the datasheet
- Application
- Biochemical assays, protein-protein interaction studies, enzyme activity regulation research
Background and Biological Significance of GCKR
Glucokinase Regulatory Protein (GCKR), encoded by the GCKR gene, is a liver-expressed protein that plays a central role in glucose homeostasis by regulating the activity of glucokinase (GCK, hexokinase IV). GCKR sequesters GCK in the nucleus under fasting or low-glucose conditions, thereby limiting hepatic glucose phosphorylation. Upon feeding or elevation of fructose-1-phosphate, GCKR releases GCK into the cytoplasm, enabling glucose metabolism.
Variants in the GCKR gene are among the most replicated genetic associations with fasting triglycerides, fasting glucose, and risk of type 2 diabetes identified in genome-wide association studies (GWAS). Recombinant Human GCKR Protein (rp367929) enables in vitro reconstitution of this regulatory axis, supporting mechanistic studies, drug discovery, and metabolic research.
Materials and Equipment Required
Before beginning, ensure the following materials and equipment are available:
- Recombinant Human GCKR Protein (rp367929, Aladdin Scientific)
- Sterile, nuclease-free water or manufacturer-recommended reconstitution buffer
- Low-protein-binding microcentrifuge tubes (1.5 mL)
- Micropipettes and calibrated tips
- Benchtop microcentrifuge
- Spectrophotometer or fluorometer for protein quantification (e.g., BCA or Bradford assay reagents)
- SDS-PAGE or Western blot apparatus for quality verification
- Dry ice or liquid nitrogen for snap-freezing aliquots
- -80°C freezer for long-term storage
- Appropriate assay buffers for downstream functional experiments
Consult the product datasheet (absea#PP-5745) for lot-specific concentration, purity, and formulation details prior to use.
Step-by-Step Protocol: Reconstitution, Aliquoting, and Storage
Step 1 – Thawing: Remove the vial from -80°C storage and thaw gently on ice (4°C). Do not thaw at room temperature or in a water bath, as rapid temperature changes can cause protein aggregation and loss of activity.
Step 2 – Centrifugation: Briefly centrifuge the vial (1,000–2,000 × g, 30 seconds) to collect any lyophilized material or condensate at the bottom of the tube before opening.
Step 3 – Reconstitution: Add the recommended volume of sterile water or reconstitution buffer as specified in the product datasheet to achieve the desired working concentration. Gently pipette to mix; avoid vortexing, which can denature the protein. Allow the protein to dissolve for 10–15 minutes on ice.
Step 4 – Quantification: Determine the actual protein concentration using a BCA or Bradford assay against a BSA standard curve. Record the lot-specific concentration for reproducibility.
Step 5 – Aliquoting: Divide the reconstituted protein into single-use aliquots using low-protein-binding tubes. Aliquot sizes should reflect the volume required for one experiment to minimize freeze-thaw cycles.
Step 6 – Snap-Freezing and Storage: Snap-freeze aliquots in liquid nitrogen or on dry ice, then transfer to -80°C for long-term storage. For short-term use (within 48 hours), store at 4°C. Repeated freeze-thaw cycles (more than 2–3) are strongly discouraged as they significantly reduce protein activity and integrity.
Step 7 – Quality Check: Before each experiment, verify protein integrity by SDS-PAGE under denaturing conditions and confirm purity by Coomassie staining or Western blot using an anti-GCKR antibody.
Functional Assay Integration and Experimental Considerations
Recombinant Human GCKR Protein is primarily used in studies examining its inhibitory and activating interactions with glucokinase (GCK). Key experimental considerations include:
GCK Inhibition Assay: GCKR forms a tight 1:1 complex with GCK in the absence of fructose-1-phosphate (F1P), sequestering it and reducing glucose phosphorylation activity. To reconstitute this interaction in vitro, combine GCKR and GCK at equimolar ratios in assay buffer (typically 25 mM HEPES pH 7.4, 150 mM NaCl, 5 mM MgCl₂) and measure GCK activity using a glucose-6-phosphate dehydrogenase (G6PDH)-coupled spectrophotometric assay (NADH formation at 340 nm).
F1P Activation Assay: To study the release of GCK from the GCKR-GCK complex, supplement the reaction with varying concentrations of fructose-1-phosphate (typically 0.01–1 mM) and monitor the restoration of GCK activity.
Protein–Protein Interaction Studies: GCKR can be used as bait or prey in pull-down assays, surface plasmon resonance (SPR), or isothermal titration calorimetry (ITC) to characterize binding kinetics and affinity with GCK or novel interaction partners.
Important Notes: Include appropriate positive controls (active GCK alone) and negative controls (heat-inactivated GCKR or buffer only). Ensure all assay components are at the same temperature (typically 25°C or 37°C) before initiating reactions. Pre-incubate GCKR with GCK for at least 10 minutes prior to adding substrates to allow complex formation.
Troubleshooting and Quality Assurance
The following table summarizes common issues encountered when working with Recombinant Human GCKR Protein and recommended corrective actions:
Issue: Protein aggregation after reconstitution.
Possible Cause: Reconstitution buffer incompatibility, excessive pipetting force, or rapid thawing.
Solution: Use manufacturer-recommended buffer, reconstitute gently on ice, and ensure vial is centrifuged before opening.
Issue: Low or absent GCK inhibitory activity.
Possible Cause: Protein denaturation due to improper storage or excess freeze-thaw cycles; incorrect molar ratio of GCKR to GCK.
Solution: Use freshly thawed aliquots; verify protein integrity by SDS-PAGE; titrate GCKR:GCK molar ratio (start at 1:1, test up to 3:1).
Issue: High background in coupled enzyme assay.
Possible Cause: Contaminating enzymatic activity in the GCKR preparation or buffer components.
Solution: Run a no-GCK control to assess background NADH generation; use high-purity assay-grade reagents.
Issue: Inconsistent results between batches.
Possible Cause: Lot-to-lot variability in protein concentration or activity.
Solution: Always quantify each aliquot independently before use; maintain consistent assay conditions across experiments.
For unresolved issues, contact Aladdin Scientific technical support, referencing the product SKU (rp367929) and lot number from the Certificate of Analysis.
Frequently asked questions
What is the recommended reconstitution buffer for Recombinant Human GCKR Protein (rp367929)?
The recommended reconstitution buffer is specified in the product datasheet (absea#PP-5745) and may include sterile water or a physiological buffer such as PBS or HEPES-based buffer. Always consult the lot-specific Certificate of Analysis for the most accurate guidance, as formulation details may vary between lots.
How many freeze-thaw cycles can Recombinant Human GCKR Protein tolerate without significant loss of activity?
It is generally recommended to limit freeze-thaw cycles to no more than 2–3 for recombinant proteins to preserve activity and structural integrity. To minimize repeated freeze-thaw events, divide reconstituted protein into single-use aliquots before snap-freezing and storing at -80°C.
Can Recombinant Human GCKR Protein be used directly in cell-based assays?
Recombinant Human GCKR Protein is primarily validated for biochemical and in vitro binding assays. Use in cell-based systems may require additional optimization, including confirmation of cell permeability or use of transfection/microinjection strategies. Consult the product datasheet for validated applications and contact Aladdin Scientific technical support for application-specific guidance.
How do I verify the purity and integrity of the GCKR protein before my experiment?
Run an aliquot of the reconstituted protein on a denaturing SDS-PAGE gel and visualize by Coomassie staining to assess purity (a single predominant band at the expected molecular weight is expected). Western blot using a validated anti-GCKR antibody can confirm protein identity. The Certificate of Analysis provided with the product should indicate the expected purity level.
What is the biological role of GCKR and why is it relevant to metabolic disease research?
GCKR (Glucokinase Regulatory Protein) controls hepatic glucose sensing by regulating glucokinase (GCK) localization and activity. Dysregulation of this system is associated with impaired glucose homeostasis, elevated fasting triglycerides, and increased risk of type 2 diabetes. Common GCKR variants identified in GWAS studies make it a key target in metabolic disease research and drug discovery.
References
- Aladdin Scientific. Recombinant Human GCKR Protein, SKU rp367929. Product Datasheet absea#PP-5745.
- Matschinsky FM, Wilson DF. The Central Role of Glucokinase in Glucose Homeostasis: A Perspective 50 Years After Demonstrating the Presence of the Enzyme in Islets of Langerhans. Frontiers in Physiology. 2019.
- Rees MG, Wincovitch S, Schultz J, et al. Cellular characterisation of the GCKR p.Pro446Leu variant associated with type 2 diabetes risk. Diabetologia. 2012.
- Van Schaftingen E. A protein from rat liver confers to glucokinase the property of being antagonized by physiological concentrations of fructose 6-phosphate. European Journal of Biochemistry. 1989.
Products are supplied for research and development use only. Not for use in humans, animals, diagnosis, or therapy.
危险品化学品经营许可证(带存储)